Buy Rebetol
Rebetol

5.26
An antiviral medication used specifically in combination therapy for patients with chronic Hepatitis C.


Ingredient
Category
Availability
In Stock
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Alternative/Local Brand
Rebetol
Active Ingredient(s)
Ribavirin
Primary Category
Antiviral
Therapeutic Class
Antivirals for systemic use, Direct acting antivirals, Nucleosides and nucleotides
Pharmacological Class
Nucleoside Analogue
Indications
Chronic Hepatitis C
Contraindications
Pregnancy, Men whose female partners are pregnant, Severe heart disease, Severe kidney disease
Minor Side Effects
Fatigue, Nausea, Muscle aches
Moderate Side Effects
Anaemia, Skin rash, Insomnia, Irritability
Serious Side Effects
Severe depression, Haemolytic anaemia, Vision changes, Difficulty breathing
Dosage Forms
Capsule, Oral solution
Administration Route
Oral
Mechanism of Action
Ribavirin interferes with the replication of viral RNA. When used in combination with other medications, it helps the immune system clear the Hepatitis C virus from the liver.
Prescription Status
Rx
Manufacturer
MSD (Merck & Co.)
Patient Summary
An antiviral medication used specifically in combination therapy for patients with chronic Hepatitis C.
Onset Time
Varies by viral load
Duration
Highly variable (stays in body for months)
Storage Instructions
Store at room temperature.
Drug Interactions
Didanosine, Zidovudine, Azathioprine
Age Restrictions
Approved for children 3 years and older in specific combinations.
Pregnancy Use
Highly contraindicated; strictly category X. Effective contraception required.
Alternative Drugs
Copegus, Modiba

What is Rebetol?

Rebetol is a brand-name medication that contains the antiviral active ingredient ribavirin. It is supplied as a 200 mg pill and belongs to the therapeutic class of antivirals. In Hong Kong, Rebetol is a prescription (Rx) product approved by the Department of Health for use in combination therapy for chronic hepatitis C infection. Ribavirin is also marketed under other brand names worldwide, such as Copegus and Virazole.

How Rebetol Works in the Body

Ribavirin is a synthetic nucleoside analogue that interferes with viral replication. After oral absorption, it is phosphorylated inside cells to ribavirin-monophosphate, diphosphate, and triphosphate forms. These active metabolites:

  • Inhibit the viral RNA-dependent RNA polymerase, reducing synthesis of viral RNA.
  • Induce lethal mutagenesis in RNA viruses, increasing mutation rates beyond a viable threshold.
  • Impair viral mRNA capping, hindering protein translation.

The drug’s antiviral activity is broad, covering many RNA viruses, which is why ribavirin is used in combination with interferon-α for hepatitis C and investigated for other viral infections. Onset of action occurs within a few days of dosing, with a half-life of 12 hours for the parent compound and up to 120 hours for its intracellular phosphorylated forms, supporting once- or twice-daily dosing schedules.

Conditions Treated by Rebetol

Rebetol is approved in Hong Kong for:

  • Chronic hepatitis C infection in combination with interferon-α or pegylated interferon-α. The regimen is intended for adult patients with genotype 1, 2, 3, or 4 hepatitis C virus (HCV) infection, as defined by local clinical guidelines.

Ribavirin alone is not approved for monotherapy in hepatitis C; its antiviral effect is synergistic when paired with interferon-based regimens.

Off-Label and Investigational Uses

Evidence-Based Off-Label Uses

  • Respiratory syncytial virus (RSV) infection in high-risk infants: Several randomized controlled trials have demonstrated modest reductions in hospitalization duration when ribavirin is inhaled. This application is not approved by Hong Kong regulatory authorities and requires careful risk-benefit assessment.

  • Lassa fever and other viral hemorrhagic fevers: Observational studies suggest possible benefit, but evidence remains limited. Use is considered experimental and should occur only within clinical research protocols.

Disclaimer: Off-label use of Rebetol requires supervision by a qualified healthcare professional, and the benefits and risks must be evaluated on an individual basis.

Who Should Not Use Rebetol?

Absolute Contraindications

  • Known hypersensitivity to ribavirin or any tablet excipient.
  • Pregnancy (including attempts to become pregnant) and lactation - ribavirin is teratogenic and may cause fetal harm.
  • Severe, uncontrolled anemia (hemoglobin < 10 g/dL) - ribavirin can exacerbate hemolysis.

Relative Contraindications

  • Renal impairment (creatinine clearance < 50 mL/min) - dose adjustment may be needed.
  • Severe hepatic dysfunction (Child-Pugh class C) - careful monitoring required.
  • Concurrent use of other hemolytic agents (e.g., azathioprine, dapsone) - increased risk of anemia.

Special Populations

  • Women of child-bearing potential: Must use reliable contraception during treatment and for at least 6 months after discontinuation.
  • Elderly patients: May require dose modification based on renal function.
  • Pediatric patients: Rebetol is not approved for use in children under 18 years for hepatitis C; off-label use in RSV is limited to specialized settings.

Safety Profile: Side Effects and Interactions

Common Side Effects

  • Fatigue - frequently reported, usually mild.
  • Headache - may improve with adequate hydration.
  • Anemia (hemolytic) - gradual decline in hemoglobin is typical; regular monitoring is essential.
  • Nausea or loss of appetite - often transient.

Serious Adverse Events

  • Severe hemolytic anemia - may require blood transfusion; watch for dark urine, pallor, and dyspnea.
  • Depression or suicidal ideation - especially when combined with interferon.
  • Teratogenic effects - congenital malformations reported in animal studies and rare human cases.

Drug Interactions

  • Azathioprine, mercaptopurine, or other thiopurines - additive bone-marrow suppression.
  • Didanosine - increased risk of pancreatic toxicity.
  • Nelfinavir and other protease inhibitors - may elevate ribavirin plasma levels.
  • Warfarin - potential for altered INR; monitor coagulation parameters.

If you are taking any other prescription medicines, over-the-counter drugs, herbal supplements, or vitamins, inform your healthcare provider before starting Rebetol.

Food and Lifestyle Interactions

  • Take with food - improves gastrointestinal tolerance.
  • Alcohol - can worsen liver injury; limit intake per physician guidance.
  • Driving or operating machinery: Ribavirin does not directly impair cognition, but fatigue or anemia may affect performance; use caution if symptoms are present.

How to Take Rebetol

  • Formulation: White, round 200 mg tablets (pill).
  • Standard dosing: Rebetol is supplied in 200 mg strength; the total daily dose is determined by the treating physician based on weight, renal function, and the specific hepatitis C regimen. Common practice involves taking multiple tablets to reach the prescribed total daily amount (e.g., 1 g = five 200 mg tablets divided into two doses).
  • Administration: Swallow whole with a full glass of water; tablets can be taken with or without food, though taking them with meals may reduce nausea.
  • Missed dose: Take the missed dose as soon as remembered unless the next scheduled dose is within 6 hours; do not double the dose.
  • Overdose: Symptoms may include severe nausea, vomiting, and marked hemolysis. Seek emergency medical care; supportive measures and blood transfusion are mainstays. No specific antidote exists.
  • Discontinuation: Abrupt cessation may lead to a rebound of viral replication. Tapering is not required for ribavirin itself, but the overall hepatitis C regimen should be adjusted by the provider.

Dosing must always be individualized; the information above reflects the available 200 mg tablet strength and does not replace professional medical advice.

Monitoring and Follow-Up

  • Complete blood count (CBC) with hemoglobin - baseline, then every 2-4 weeks during therapy.
  • Renal function tests - serum creatinine and eGFR at baseline and periodically.
  • Liver enzymes - to assess hepatic response to hepatitis C treatment.
  • Pregnancy testing - for women of child-bearing potential before initiating therapy and monthly thereafter.
  • Thyroid function - if interferon is co-administered, as interferon can affect thyroid status.

Patients should contact their healthcare provider promptly if they experience signs of severe anemia, shortness of breath, or unexplained bruising.

Storage and Handling

  • Store Rebetol tablets at room temperature (20 °C-25 °C), away from excess heat, moisture, and direct sunlight.
  • Keep the container tightly closed and out of reach of children.
  • Do not use the medication after the printed expiration date.
  • Dispose of unused tablets according to local pharmacy take-back programs or municipal hazardous waste guidelines.

Medication-Specific Glossary

Hemolytic anemia
A condition where red blood cells are destroyed faster than they can be produced, commonly induced by ribavirin’s effect on erythrocytes.
Teratogenicity
The capability of a substance to cause birth defects; ribavirin is classified as a Category X teratogen in many jurisdictions.
Pharmacokinetics
The study of how a drug is absorbed, distributed, metabolized, and excreted; ribavirin exhibits a long intracellular half-life due to its phosphorylated metabolites.
Combination therapy
Use of two or more medications together to achieve a synergistic therapeutic effect; for hepatitis C, ribavirin is paired with interferon-α.

Medical Disclaimer

This article provides educational information about Rebetol and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Rebetol FAQ

Can I travel internationally with Rebetol pills?

Yes, you may travel with Rebetol, but you should carry the prescription label, a copy of the prescribing information, and a letter from your physician if you are crossing borders where medication inspection occurs. Keep the tablets in their original container to avoid confusion.

What does a Rebetol tablet look like?

Rebetol tablets are typically round, white, and marked with the imprint “RIB 200” on one side, indicating the 200 mg ribavirin strength.

Does Rebetol appear on drug-testing panels for employment or sports?

Ribavirin is not a controlled substance and is not routinely screened for in standard occupational drug tests or most sports anti-doping panels. However, specific programs may test for antiviral agents if clinically indicated.

Are there regional differences in the packaging of Rebetol?

In Hong Kong, Rebetol is packaged in blister packs of 30 tablets per strip, each strip labeled with the Hong Kong Drug Office registration number. Other markets may use bottle packaging or different strip sizes.

How does Rebetol compare to other ribavirin brands like Copegus?

All ribavirin brands contain the same active ingredient and 200 mg tablet strength. Differences lie mainly in excipients, packaging, and branding; therapeutic efficacy and safety are equivalent when dosing is correctly matched.

What should I do if I miss a dose while on a strict dosing schedule?

Take the missed dose as soon as you remember unless the next scheduled dose is due within 6 hours. In that case, skip the missed dose and continue with the regular schedule. Never double a dose without consulting your prescriber.

Can Rebetol be taken with food or should it be taken on an empty stomach?

Rebetol can be taken with or without food. Taking it with meals may reduce gastrointestinal discomfort, which some patients experience.

Is there a generic version of Rebetol available in Hong Kong?

Yes, ribavirin is also marketed as a generic medication in Hong Kong. It contains the same 200 mg tablet strength and is subject to the same prescribing regulations.

How long can I store unused Rebetol before it expires?

Check the expiration date printed on the packaging. Generally, ribavirin tablets retain full potency for up to three years when stored at room temperature, protected from moisture and heat. Discard any tablets past their expiration date.

Categories